Emerging biomarkers for improving pregnancy planning in multiple sclerosis

ConclusionWe found no significant differences in AMH, sNfL or GFAP values between MS patients and the control group within any of the age-matched categories. The assessment of AMH, sNFL and GFAP levels at MS onset facilitates personalized therapeutic and family planning strategies for childbearing-age women.
Source: Frontiers in Neurology - Category: Neurology Source Type: research